Veeva Systems Inc. (VEEV) P/E Ratio History
Deep ValueTrading at 35.3x · 5th percentile of 5-year range · Significant discount to historical valuation · Data 2014–2027
Loading P/E history...
P/E Ratio Analysis
As of July 8, 2026, Veeva Systems Inc. (VEEV) trades at a price-to-earnings ratio of 35.3x, with a stock price of $192.30 and trailing twelve-month earnings per share of $5.67.
The current P/E is 46% below its 5-year average of 65.4x. Over the past five years, VEEV's P/E has ranged from a low of 27.8x to a high of 127.0x, placing the current valuation at the 5th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.4x, VEEV trades at a 51% premium to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 198.8x.
The PEG ratio of 1.94 (P/E divided by 26% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, VEEV commands a significant premium over the S&P 500 median P/E of 25.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our VEEV DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
VEEV Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
VEEV P/E vs Peers
Life Sciences and Precision Medicine Software peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $139B | 21.7 | 1.78 | +23% | |
| $4B | 23.2 | 0.44Best | -12% | |
| $16B | 35.8 | 1.12 | +21% | |
| $11B | 238.6 | - | +863%Best | |
| $6B | 37.7 | 1.47 | +16% | |
| $137B | 17.7Lowest | - | -4% | |
| $643B | 24.2 | 1.63 | +91% | |
| $318B | 17.7 | 0.83 | +8% | |
| $1.2T | 53.8 | 1.87 | +96% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
VEEV Historical P/E Data (2014–2027)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2027 Q1 | - | $155.96 | $5.61 | 27.8x | -69% |
| FY2026 Q4 | Jan 31 2026 | $203.92 | $5.41 | 37.7x | -58% |
| FY2026 Q3 | Oct 31 2025 | $291.20 | $5.13 | 56.8x | -37% |
| FY2026 Q2 | - | $284.20 | $4.86 | 58.5x | -35% |
| FY2026 Q1 | Apr 30 2025 | $233.69 | $4.71 | 49.6x | -45% |
| FY2025 Q4 | Jan 31 2025 | $233.26 | $4.32 | 54.0x | -40% |
| FY2025 Q3 | - | $208.83 | $4.05 | 51.6x | -42% |
| FY2025 Q2 | Jul 31 2024 | $191.93 | $3.75 | 51.2x | -43% |
| FY2025 Q1 | - | $198.56 | $3.39 | 58.6x | -35% |
| FY2024 Q4 | Jan 31 2024 | $207.41 | $3.22 | 64.4x | -28% |
| FY2024 Q3 | - | $192.71 | $3.48 | 55.4x | -38% |
| FY2024 Q2 | Jul 31 2023 | $204.22 | $3.32 | 61.5x | -31% |
| FY2024 Q1 | Apr 30 2023 | $179.08 | $3.20 | 56.0x | -38% |
| FY2023 Q4 | - | $170.55 | $3.01 | 56.7x | -37% |
| FY2023 Q3 | Oct 31 2022 | $167.94 | $2.45 | 68.5x | -23% |
| FY2023 Q2 | Jul 31 2022 | $223.58 | $2.43 | 92.0x | +3% |
| FY2023 Q1 | Apr 30 2022 | $181.95 | $2.54 | 71.6x | -20% |
| FY2022 Q4 | Jan 31 2022 | $236.54 | $2.63 | 89.9x | +0% |
| FY2022 Q3 | Oct 31 2021 | $317.01 | $2.67 | 118.7x | +33% |
| FY2022 Q2 | Jul 31 2021 | $332.71 | $2.62 | 127.0x | +42% |
| FY2022 Q1 | Apr 30 2021 | $282.45 | $2.53 | 111.6x | +25% |
| FY2021 Q4 | Jan 31 2021 | $276.44 | $2.36 | 117.1x | +31% |
| FY2021 Q3 | Oct 31 2020 | $270.05 | $2.14 | 126.2x | +41% |
| FY2021 Q2 | Jul 31 2020 | $264.57 | $2.06 | 128.4x | +43% |
| FY2021 Q1 | - | $190.80 | $1.98 | 96.4x | +8% |
| FY2020 Q4 | Jan 31 2020 | $146.61 | $1.91 | 76.8x | -14% |
| FY2020 Q3 | - | $141.83 | $1.94 | 73.1x | -18% |
| FY2020 Q2 | Jul 31 2019 | $165.90 | $1.83 | 90.7x | +1% |
| FY2020 Q1 | - | $139.87 | $1.65 | 84.8x | -5% |
| FY2019 Q4 | - | $109.06 | $1.47 | 74.2x | -17% |
| FY2019 Q3 | Oct 31 2018 | $91.35 | $1.24 | 73.7x | -18% |
| FY2019 Q2 | - | $75.63 | $1.06 | 71.3x | -20% |
| FY2019 Q1 | Apr 30 2018 | $70.13 | $0.99 | 70.8x | -21% |
| FY2018 Q4 | Jan 31 2018 | $62.86 | $0.94 | 66.9x | -25% |
| FY2018 Q3 | - | $60.94 | $0.87 | 70.0x | -22% |
| FY2018 Q2 | Jul 31 2017 | $63.76 | $0.79 | 80.7x | -10% |
| FY2018 Q1 | Apr 30 2017 | $53.62 | $0.63 | 85.1x | -5% |
| FY2017 Q4 | - | $42.33 | $0.48 | 88.2x | -2% |
| FY2017 Q3 | Oct 31 2016 | $38.85 | $0.45 | 86.3x | -4% |
| FY2017 Q2 | Jul 31 2016 | $37.99 | $0.37 | 102.7x | +15% |
| FY2017 Q1 | Apr 30 2016 | $27.51 | $0.37 | 74.4x | -17% |
| FY2016 Q4 | Jan 31 2016 | $24.10 | $0.37 | 65.1x | -27% |
| FY2016 Q3 | Oct 31 2015 | $25.37 | $0.34 | 74.6x | -17% |
| FY2016 Q2 | Jul 31 2015 | $26.92 | $0.34 | 79.2x | -12% |
| FY2016 Q1 | - | $26.55 | $0.32 | 83.0x | -7% |
| FY2015 Q4 | Jan 31 2015 | $28.76 | $0.28 | 102.7x | +15% |
| FY2015 Q3 | Oct 31 2014 | $29.78 | $0.23 | 129.5x | +45% |
| FY2015 Q2 | - | $23.80 | $0.21 | 113.3x | +27% |
| FY2015 Q1 | Apr 30 2014 | $19.21 | $0.15 | 127.7x | +43% |
| FY2014 Q4 | Jan 31 2014 | $31.79 | $0.11 | 294.1x | +228% |
| FY2014 Q3 | - | $38.91 | $0.11 | 340.7x | +281% |
Average P/E for displayed period: 89.5x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VEEV — Frequently Asked Questions
Quick answers to the most common questions about buying VEEV stock.
What is VEEV's P/E ratio?
Veeva Systems Inc. (VEEV) trailing twelve-month P/E ratio is 35.3x, based on TTM diluted EPS of $5.67. The 5-year average P/E is 65.4x and the historical range spans 27.8x to 127.0x.
Is VEEV stock overvalued or undervalued?
VEEV trades at 35.3x P/E, below its 5-year average of 65.4x. At the 5th percentile of its historical range (27.8x–127.0x), the stock is priced at a discount to its own history.
Is VEEV stock expensive?
No, VEEV is not expensive on a historical basis. The current P/E of 35.3x is below the 5-year average of 65.4x and sits at the 5th percentile of its valuation range.
What is VEEV's historical P/E range?
Over the past 5 years, VEEV's P/E ratio has ranged from 27.8x to 127.0x, with a median of 58.5x and an average of 65.4x. The current P/E of 35.3x places the stock at the 5th percentile of this range. Full historical data spans 2014–2027.
How does VEEV's P/E compare to the S&P 500?
VEEV trades at 35.3x P/E versus the S&P 500 median of 25.9x. The 36% premium to the market typically reflects higher expected earnings growth or quality.
How does VEEV's valuation compare to Healthcare peers?
Veeva Systems Inc. P/E of 35.3x compares to the Healthcare sector median of 23.4x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is VEEV's PEG ratio?
VEEV PEG ratio is 1.94, based on a P/E of 35.3x and EPS growth of 25.9%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is VEEV's earnings yield?
VEEV earnings yield is 2.83%, the inverse of its 35.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.